Near future
No Result
View All Result
February 4 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

First human tests of the brain cancer vaccine completed

An "Achilles heel" of brain cancer led to a vaccine tested by mice in 2019. Today, phase 1 has also started in humans.

READ THIS IN:

EN CN FR DE JA PT RU ES
Share25Pin7Tweet16SendShare4ShareShare3
Brain cancer
March 28 2021
Gianluca RiccioGianluca Riccio
⚪ 3 minutes

A team of German scientists has tested a special vaccine in humans for the first time designed to help the body fight brain cancer.

As explained in a new article published in the magazine Nature , the research team of the German Cancer Research Center (DFKZ) created a first version of a vaccination that could trigger an immune response within the tissues of a brain cancer.

Some types of brain cancer are now incurable. They are called diffuse gliomas and can spread throughout the brain making them nearly impossible to remove. In addition, they often do not respond effectively to chemo and radiation therapy.

But they seem to have a weakness: a particular genetic mutation.

The killer's signature

A kind of "bug" in the DNA causes a special protein to be exchanged for the IDH1 enzyme, a protein structure known as "neo-epitope". The immune system is able to recognize this protein as foreign, plus it is not found in healthy tissues. This makes her the perfect target for a treatment.

Our idea was to support the immune system of patients with brain cancer and to use a vaccine as a targeted way to alert them to that specific neo-epitope. cancer

Michael Platten, at the head of the research - excerpt from Press release
Brain Cancer Vaccine
Michael Platten

New brain cancer vaccine research

It is not an attempt that is born today. This recent study builds on previous efforts to create an artificial version of the IDH1 segment responsible for the genetic mutation that "unmasks" brain cancer. In 2019, the first version of a preparation was able to stop the growth of cancer cells in mice.

The article continues after the related links

Approved the first vaccine against plague of bees

Artificial DNA unleashed against cancer cells: a world first

Today, the same team hopes the treatment will work in these first Phase 1 human clinical trials, involving 33 patients across Germany. No side effects were recorded in vaccinated patients. Approximately 93% of patients showed a response to vaccines and 84% of vaccinated patients survived beyond three years after treatment.

Brain Cancer Vaccine
The DFKZ laboratory in a phase of the study.

Brain Cancer Vaccine Phase 1: It went well, but how good?

It is still impossible to say, caution is needed. "We can't draw any further conclusions about vaccine efficacy from this first study without a control group," says Platten. "The safety and immunogenicity are so compelling that we continued to pursue vaccine development in an additional Phase I study."

I will keep you informed on the future developments of this research.

Tags: cancerbrain cancervaccines

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Most read in the week

  • 'AI lawyer' to assist client in a lawsuit: first time in the world

    1368 Shares
    Share 547 Tweet 342
  • I tested for you GPTZero, the weapon against the invasion of automatic texts.

    442 Shares
    Share 176 Tweet 110
  • Akio Toyoda has an idea: instead of new cars, we convert existing ones

    369 Shares
    Share 147 Tweet 92
  • Giant wind turbines like skyscrapers, a new study makes them possible

    315 Shares
    Share 126 Tweet 79
  • 27 jobs that will disappear within 50 years

    2836 Shares
    Share 1134 Tweet 709

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok
  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Inland solutions
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Русское издание
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP

© 2022 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+